Article
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Experimental hematology - 1 Oct 2007
Lagneaux Laurence, Gillet Nicolas, Stamatopoulos Basile, Delforge Alain, Dejeneffe Marielle, Massy Martine, Meuleman Nathalie, Kentos Alain, Martiat Philippe, Willems Luc, Bron Dominique
Abstract excerpt
OBJECTIVE: Chronic lymphocytic leukemia (CLL) cells develop chemoresistance over time associated with defects in apoptosis pathway. Novel treatment strategies are required to overcome resistance of cells to commonly used agents. The effects of valproic acid (VPA), an antiepileptic drug with histone deacetylase inhibitory activity, on mononuclear cells isolated from 40 CLL patients were evaluated. METHODS: CLL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
